Semi-Annual Statement Of Cash Flows

KYORIN Pharmaceutical Co., Ltd. - Filing #7603167

Concept 2021-04-01 to
2022-03-31
As at
2022-03-31
As at
2021-03-31
2020-04-01 to
2021-03-31
As at
2020-03-31
Semi-annual statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
7,240,000,000 JPY
6,728,000,000 JPY
Interest and dividends received
420,000,000 JPY
428,000,000 JPY
Interest paid
-66,000,000 JPY
-68,000,000 JPY
Income taxes paid
-1,248,000,000 JPY
-1,899,000,000 JPY
Net cash provided by (used in) operating activities
6,346,000,000 JPY
5,189,000,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-2,444,000,000 JPY
-4,067,000,000 JPY
Proceeds from sale of property, plant and equipment
0 JPY
368,000,000 JPY
Purchase of investment securities
-3,407,000,000 JPY
-1,407,000,000 JPY
Other, net
-185,000,000 JPY
-134,000,000 JPY
Net cash provided by (used in) investing activities
-2,560,000,000 JPY
-4,259,000,000 JPY
Cash flows from financing activities
Proceeds from long-term borrowings
JPY
0 JPY
Repayments of long-term borrowings
-200,000,000 JPY
-428,000,000 JPY
Dividends paid
-3,767,000,000 JPY
-4,347,000,000 JPY
Net cash provided by (used in) financing activities
-4,112,000,000 JPY
-4,918,000,000 JPY
Effect of exchange rate change on cash and cash equivalents
139,000,000 JPY
-43,000,000 JPY
Net increase (decrease) in cash and cash equivalents
-186,000,000 JPY
-4,033,000,000 JPY
Cash and cash equivalents
26,289,000,000 JPY
26,476,000,000 JPY
30,509,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.